A recent study indicates that individuals who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a leading medical journal demonstrates that while overweight individuals can lose a large proportion of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications must be cognizant of the danger of rapid rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment weight in about 18 months.
Weighing Therapies
The study, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers point out that people who lose weight through dieting usually see a slower creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Fast Regain
Doctors believe the way of the jabs is key to understanding the heightened weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in hunger is unsuppressed, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, due to the likelihood of relapse, the therapy should be considered long-term.
This perspective is echoed by drug manufacturers, who say that the results "highlight the long-term character of excess weight," comparing it to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the jabs explain a powerful resurgence of cravings.
"It felt as if a switch flipping and you're instantly extremely hungry," described an individual.
This challenge is exacerbated if individuals have not established lasting dietary or behavioural changes during treatment.
Significant Use
Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while these medications are potent agents for shedding pounds, they are not a standalone cure and maintained weight loss hinges on ongoing behavioural support.
